levodopa has been researched along with Bone Diseases, Metabolic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatani, M; Handa, K; Hosonuma, M; Inagaki, K; Ishikawa, K; Karakawa, A; Kiuchi, Y; Kiyohara, S; Negishi-Koga, T; Sakai, N; Takami, M; Tsuji, M; Yamakawa, T | 1 |
| Abe, H; Harada, T; Ishizaki, F; Katayama, S; Nakamura, S | 1 |
2 other study(ies) available for levodopa and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Bone loss caused by dopaminergic degeneration and levodopa treatment in Parkinson's disease model mice.
Topics: Animals; Antiparkinson Agents; Bone Diseases, Metabolic; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Female; Levodopa; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Osteoporosis; Parkinson Disease | 2019 |
Relationship between osteopenia and clinical characteristics of Parkinson's disease.
Topics: Absorptiometry, Photon; Aged; Bone Diseases, Metabolic; Female; Humans; Levodopa; Locomotion; Male; Middle Aged; Parkinson Disease | 1993 |